Brevan Howard Capital Management’s Altimmune ALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$516K	Buy	133,209 +89,405	+204%	+$346K	﹤0.01%	1256
2025 Q1	$219K	Buy	43,804 +29,773	+212%	+$149K	﹤0.01%	908
2024 Q4	$101K	Buy	+14,031	New	+$101K	﹤0.01%	936
2024 Q3	–	Sell	-32,454	Closed	-$216K	–	1061
2024 Q2	$216K	Buy	+32,454	New	+$216K	﹤0.01%	812